HLB Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20,311	17,934	23,709	45,821	99,873
Short-Term Investments	2,500	9,567	8,644	18,101	560
Trading Asset Securities	23,187	10,272	-	89.45	134.25
Cash & Short-Term Investments	45,998	37,773	32,353	64,012	100,567
Cash Growth	21.78%	16.75%	-49.46%	-36.35%	249.37%
Accounts Receivable	14,306	8,626	9,497	7,900	6,448
Other Receivables	363.75	165.82	339.49	625.47	1,442
Receivables	14,670	8,792	9,837	8,527	8,874
Inventory	7,237	5,373	5,336	6,455	2,345
Prepaid Expenses	288.01	274.38	161.96	151.72	133.07
Other Current Assets	6,308	1,913	2,138	865.59	1,333
Total Current Assets	74,500	54,125	49,825	80,012	113,253
Property, Plant & Equipment	8,857	9,530	10,068	15,780	9,781
Long-Term Investments	43,089	61,804	58,608	20,335	3,715
Goodwill	5,388	5,388	5,388	1,075	382.08
Other Intangible Assets	6,532	5,399	4,896	4,260	3,925
Long-Term Deferred Tax Assets	2,007	-	-	-	-
Long-Term Deferred Charges	85,592	78,283	69,100	63,472	57,586
Other Long-Term Assets	2,690	5,264	2,910	2,709	1,070
Total Assets	228,655	219,793	200,795	187,643	189,711
Accounts Payable	5,361	4,817	8,183	2,517	1,272
Accrued Expenses	1,925	1,106	902.2	1,510	1,819
Short-Term Debt	10,768	17,531	7,436	51,551	50,441
Current Portion of Long-Term Debt	-	-	-	98	-
Current Portion of Leases	1,445	450.97	624.24	297.68	364.54
Current Income Taxes Payable	806.4	-	-	-	-
Other Current Liabilities	5,909	8,000	9,645	2,655	2,820
Total Current Liabilities	26,214	31,904	26,791	58,628	56,717
Long-Term Debt	25,359	5,170	1,840	48	-
Long-Term Leases	2,978	200.58	122.2	136.74	320.7
Pension & Post-Retirement Benefits	-	454.67	328.13	520.44	2,440
Other Long-Term Liabilities	240.42	194.81	194.81	194.81	194.81
Total Liabilities	54,792	37,925	29,276	59,528	59,672
Common Stock	42,191	40,070	37,016	15,992	15,668
Additional Paid-In Capital	87,865	136,440	125,176	97,290	190,850
Retained Earnings	10,597	-30,176	-4,862	-1,916	-90,644
Treasury Stock	-1,474	-1,120	-483.65	-413.53	-413.53
Comprehensive Income & Other	11,075	12,250	3,620	5,754	3,219
Total Common Equity	150,254	157,465	160,466	116,708	118,679
Minority Interest	23,610	24,404	11,053	11,408	11,360
Shareholders' Equity	173,863	181,868	171,519	128,116	130,039
Total Liabilities & Equity	228,655	219,793	200,795	187,643	189,711
Total Debt	40,550	23,353	10,022	52,131	51,126
Net Cash (Debt)	5,448	14,420	22,330	11,881	49,441
Net Cash Growth	-62.22%	-35.42%	87.95%	-75.97%	219.98%
Net Cash Per Share	62.00	170.82	273.07	166.30	767.17
Filing Date Shares Outstanding	87.27	83.74	81.26	36.14	73.28
Total Common Shares Outstanding	87.27	87.93	81.26	72.29	73.28
Working Capital	48,286	22,221	23,034	21,384	56,536
Book Value Per Share	1721.67	1790.84	1974.62	1614.49	1619.44
Tangible Book Value	138,334	146,678	150,182	111,372	114,372
Tangible Book Value Per Share	1585.09	1668.16	1848.08	1540.68	1560.66
Land	1,439	4,429	4,429	5,916	4,429
Buildings	2,506	5,300	5,150	8,467	5,146
Machinery	7,829	7,711	2,927	10,253	2,737
Construction In Progress	16.25	-	-	263.3	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.